DBV Technologies S.A. (DBVT) stock
DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF
$11.88+0.37 (+3.21%)
Close on Nov 11, 2026Market cap $746.99MP/E –Yield –
DBV Technologies cash
Cash and short-term investments held at the end of each period.
DBV Technologies's cash was $165.70M at Sep 30, 2026. For fiscal 2025 it was $194.20M, up 497.5% from the year before. The highest annual figure on record is $209.19M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $194.20M | +497.5% |
| FY2024 | Dec 31, 2024 | $32.50M | -77.0% |
| FY2023 | Dec 31, 2023 | $141.37M | -32.4% |
| FY2022 | Dec 31, 2022 | $209.19M | +170.6% |
| FY2021 | Dec 31, 2021 | $77.30M | -60.6% |
| FY2020 | Dec 31, 2020 | $196.35M | +1.6% |
| FY2019 | Dec 31, 2019 | $193.26M | +37.5% |
| FY2018 | Dec 31, 2018 | $140.57M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $165.70M | +137.4% |
| Q2 FY2026 | Jun 30, 2026 | $174.90M | +69.5% |
| Q1 FY2026 | Mar 31, 2026 | $229.20M | +1663.1% |
| Q4 FY2025 | Dec 31, 2025 | $194.20M | +497.5% |
| Q3 FY2025 | Sep 30, 2025 | $69.80M | +50.3% |
| Q2 FY2025 | Jun 30, 2025 | $103.20M | +55.9% |
| Q1 FY2025 | Mar 31, 2025 | $13.00M | -87.2% |
| Q4 FY2024 | Dec 31, 2024 | $32.50M | -77.0% |
| Q3 FY2024 | Sep 30, 2024 | $46.44M | -68.9% |
| Q2 FY2024 | Jun 30, 2024 | $66.21M | -61.9% |
| Q1 FY2024 | Mar 31, 2024 | $101.53M | -51.5% |
| Q4 FY2023 | Dec 31, 2023 | $141.37M | -32.4% |
| Q3 FY2023 | Sep 30, 2023 | $149.14M | -29.9% |
| Q2 FY2023 | Jun 30, 2023 | $173.96M | -29.8% |
| Q1 FY2023 | Mar 31, 2023 | $209.19M | +182.3% |
| Q4 FY2022 | Dec 31, 2022 | $209.19M | +170.6% |
| Q3 FY2022 | Sep 30, 2022 | $212.67M | +116.6% |
| Q2 FY2022 | Jun 30, 2022 | $247.97M | +97.6% |
| Q1 FY2022 | Mar 31, 2022 | $74.11M | -51.4% |
| Q4 FY2021 | Dec 31, 2021 | $77.30M | -60.6% |
| Q3 FY2021 | Sep 30, 2021 | $98.20M | -55.6% |
| Q2 FY2021 | Jun 30, 2021 | $125.48M | -50.4% |
| Q1 FY2021 | Mar 31, 2021 | $152.46M | -47.0% |
| Q4 FY2020 | Dec 31, 2020 | $196.35M | +1.6% |
| Q3 FY2020 | Sep 30, 2020 | $221.40M | +57.5% |
| Q2 FY2020 | Jun 30, 2020 | $252.92M | – |
| Q1 FY2020 | Mar 31, 2020 | $287.44M | – |
| Q4 FY2019 | Dec 31, 2019 | $193.26M | – |
| Q4 FY2018 | Dec 31, 2018 | $140.57M | – |
See a number that looks wrong?